Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients: Clinical Impact of Genetic Variation in Statin Disposition

Trial Profile

Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients: Clinical Impact of Genetic Variation in Statin Disposition

Recruiting
Phase of Trial: Phase I

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
  • Indications Dyslipidaemias
  • Focus Pharmacodynamics; Pharmacogenomic
  • Most Recent Events

    • 18 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 Dec 2017.
    • 18 Jul 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2017.
    • 25 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top